Clinigen Tops Fast Track 100 League Table of UK's Fastest-Growing Companies MarketWatch (press release) Clinigen holds marketing authorisations to sell Foscavir as a treatment for HIV/AIDS-related cytomegalovirus infections and herpes in 16 markets, as well as in bone marrow transplantation in Japan. Clinigen aims to secure licences to market Foscavir in ... |
